tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Arcadia Biosciences Inc

RKDA
Add to Watchlist
0.625USD
-0.008-1.26%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.29MMarket Cap
LossP/E TTM

Arcadia Biosciences Inc

0.625
-0.008-1.26%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

RKDA Financials

See Arcadia Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Arcadia Biosciences Inc Earnings Date

Latest Release
May 14, 2026
EPS / Forecast
-2.11/-0.80
Revenue / Forecast
1.10M/1.60M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
4.86M
-3.71%
EPS(YoY)
-1.71
66.88%
Analyst Rating
BUY
2025/12/09
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-210.65%-2.11
67.29%-0.97
152.97%0.63
-518.88%-3.26
206.92%1.90
-42.10%-2.98
37.40%-1.18
28.50%0.78
83.61%-1.78
66.74%-2.10
---1.89
--0.61
---10.86
---6.30
---19.37
----
----
----
----
----
Revenue
-8.33%1.10M
-25.90%901.00K
-15.29%1.30M
11.41%1.46M
21.58%1.20M
56.50%1.22M
18.41%1.54M
0.69%1.31M
-19.89%987.00K
4.44%777.00K
-17.32%1.30M
-66.38%1.30M
-61.74%1.23M
-65.73%744.00K
-33.92%1.57M
174.59%3.86M
288.89%3.22M
-69.55%2.17M
656.69%2.38M
400.00%1.41M
Net Profit
-268.72%-4.38M
67.13%-1.34M
153.10%856.00K
-520.17%-4.46M
207.26%2.60M
-42.45%-4.06M
37.20%-1.61M
28.92%1.06M
74.18%-2.42M
32.78%-2.85M
10.46%-2.57M
121.79%823.00K
-109.09%-9.38M
54.28%-4.24M
-31.82%-2.87M
28.21%-3.78M
-318.08%-4.49M
-204.32%-9.28M
65.97%-2.17M
45.70%-5.26M
Net Margin
-284.06%-398.64%
55.34%-148.28%
185.49%65.75%
-316.30%-306.39%
325.73%216.58%
-470.70%-331.99%
-56.21%-76.90%
-41.77%141.65%
87.16%-95.95%
86.39%-58.17%
---49.23%
--243.25%
---747.00%
---427.42%
---114.59%
----
----
----
----
----
Gross Margin
-15.76%36.36%
-33.39%21.31%
-25.12%32.10%
-15.84%43.37%
-17.43%43.17%
-58.50%31.99%
-23.97%42.88%
3.30%51.53%
13.60%52.28%
-75.53%77.09%
--56.39%
--49.88%
--46.02%
--315.05%
--22.07%
----
----
----
----
----
Debt to assets ratio
--4.94%
----
--3.15%
----
----
----
----
--0.00%
--0.00%
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
Income Statement
Revenue
-8.33%1.10M
-25.90%901.00K
-15.29%1.30M
11.41%1.46M
21.58%1.20M
56.50%1.22M
18.41%1.54M
0.69%1.31M
-19.89%987.00K
4.44%777.00K
-17.32%1.30M
-66.38%1.30M
-61.74%1.23M
-65.73%744.00K
-33.92%1.57M
174.59%3.86M
288.89%3.22M
-69.55%2.17M
656.69%2.38M
400.00%1.41M
Operating profit
36.15%-779.00K
39.67%-1.38M
12.27%-1.41M
-196.53%-5.99M
21.39%-1.22M
-105.50%-2.28M
-40.26%-1.61M
-38.93%-2.02M
59.82%-1.55M
37.87%-1.11M
71.31%-1.15M
58.46%-1.45M
16.28%-3.86M
59.09%-1.79M
40.14%-3.99M
48.97%-3.50M
9.46%-4.61M
-2908.97%-4.36M
-10.86%-6.67M
-25.26%-6.86M
Net Profit
-268.72%-4.38M
67.13%-1.34M
153.10%856.00K
-520.17%-4.46M
207.26%2.60M
-42.45%-4.06M
37.20%-1.61M
28.92%1.06M
74.18%-2.42M
32.78%-2.85M
10.46%-2.57M
121.79%823.00K
-109.09%-9.38M
54.28%-4.24M
-31.82%-2.87M
28.21%-3.78M
-318.08%-4.49M
-204.32%-9.28M
65.97%-2.17M
45.70%-5.26M
Balance Sheet
Current assets
-41.57%5.17M
-31.23%6.36M
-21.70%8.39M
-39.05%7.58M
-24.02%8.85M
-38.27%9.24M
-46.46%10.71M
-46.72%12.43M
-57.21%11.64M
-41.05%14.97M
-33.38%20.01M
-22.35%23.34M
-13.63%27.20M
-28.23%25.40M
-31.49%30.03M
-40.97%30.06M
-44.36%31.50M
11.65%35.39M
106.82%43.83M
95.11%50.92M
Total current liabilities
-38.40%1.36M
-19.66%2.06M
-1.85%2.29M
-31.84%1.84M
-23.00%2.22M
-28.61%2.56M
-40.08%2.33M
-34.05%2.70M
-29.75%2.88M
-14.71%3.59M
-4.10%3.88M
-13.69%4.09M
-14.81%4.10M
-16.49%4.21M
-37.57%4.05M
-38.05%4.74M
-14.38%4.81M
-20.18%5.04M
-22.82%6.49M
-8.52%7.65M
Total assets
-59.02%5.32M
-51.57%6.55M
-43.68%8.58M
-55.16%7.79M
-19.05%12.99M
-31.40%13.52M
-35.05%15.24M
-35.19%17.37M
-47.23%16.05M
-31.87%19.70M
-31.93%23.47M
-23.45%26.80M
-21.62%30.41M
-34.15%28.92M
-41.79%34.47M
-50.55%35.01M
-45.20%38.80M
-7.24%43.92M
74.83%59.23M
87.41%70.80M
Total liabilities
-40.32%2.44M
-67.01%2.41M
-38.32%3.14M
-43.91%3.25M
-26.57%4.08M
4.17%7.29M
-36.89%5.09M
-36.01%5.80M
-59.45%5.56M
-12.72%7.00M
-14.67%8.07M
10.05%9.07M
60.31%13.72M
-36.94%8.02M
-50.25%9.46M
-70.70%8.24M
-65.90%8.56M
-32.32%12.72M
-13.12%19.00M
16.38%28.12M
Total equity
-67.60%2.88M
-33.47%4.14M
-46.37%5.44M
-60.81%4.53M
-15.05%8.90M
-51.01%6.22M
-34.09%10.15M
-34.77%11.57M
-37.20%10.48M
-39.22%12.70M
-38.45%15.40M
-33.76%17.73M
-44.81%16.69M
-33.00%20.90M
-37.80%25.02M
-37.28%26.77M
-33.83%30.24M
9.26%31.20M
235.14%40.22M
213.45%42.68M
Cash Flow Statement
Net operating income
30.79%-1.10M
61.02%-861.00K
85.33%-257.00K
17.22%-2.03M
50.53%-1.59M
46.71%-2.21M
39.27%-1.75M
48.81%-2.46M
7.39%-3.21M
-75.93%-4.14M
14.42%-2.88M
-42.59%-4.80M
29.05%-3.47M
64.62%-2.36M
59.23%-3.37M
46.01%-3.37M
-3.78%-4.88M
1.35%-6.66M
-19.50%-8.27M
14.36%-6.23M
Net investment
-100.00%0.00
-100.00%0.00
-100.00%0.00
-94.62%250.00K
12400.00%500.00K
4736.54%2.52M
3500.00%180.00K
198.45%4.64M
-98.73%4.00K
-81.49%52.00K
-98.53%5.00K
-9925.00%-4.72M
-57.83%315.00K
501.43%281.00K
267.16%341.00K
-99.72%48.00K
254.02%747.00K
-102.45%-70.00K
-12.71%-204.00K
1074.24%17.37M
Net financing
35780.00%1.79M
--0.00
-75.00%1.00K
--0.00
0.00%5.00K
--0.00
-42.86%4.00K
--0.00
-99.91%5.00K
--0.00
-99.84%7.00K
--0.00
137525.00%5.50M
100.00%0.00
21400.00%4.51M
100.00%0.00
-99.98%4.00K
-101.47%-114.00K
-99.09%21.00K
-100.04%-4.00K

FAQs

What is the total revenue of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its total revenue reached 4.86M, with a year-on-year change of 5.04M.

What are the current assets of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its current assets were 6.36M, with a year-on-year change of -31.23.

What are the total assets of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its total assets of Arcadia Biosciences Inc were 6.55M, with a year-on-year change of -51.57.

What are the total liabilities of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its total liabilities of Arcadia Biosciences Inc were 2.41M, with a year-on-year change of -67.01.

What is the total equity of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its total equity of Arcadia Biosciences Inc was 4.14M, with a year-on-year change of -33.47.

What is the net operating income of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its net operating income of Arcadia Biosciences Inc was -9.99M, with a year-on-year change of -34.02.

What is the net investment of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its net investment of Arcadia Biosciences Inc was 750.00K, with a year-on-year change of -89.78.

What is the net financing of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its net financing of Arcadia Biosciences Inc was 6.00K, with a year-on-year change of -33.33.

What is the Earnings Per Share (EPS) of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.71, with a year-on-year change of 66.88.

What is the net income of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its net income was -2.34M, with a year-on-year change of 66.77.

What is the net margin of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its net profit margin was -48.15, with a year-on-year change of 43.73.

What is the gross margin of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its gross margin was 36.23, with a year-on-year change of -18.26.

What is the debt-to-asset ratio of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its debt-to-asset ratio was 4.12, with a year-on-year change of 106.49.

What is the Return on Equity (ROE) of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -45.14, with a year-on-year change of 0.33.

What is the Return on Assets (ROA) of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -23.32, with a year-on-year change of 10.28.

What is the operating profit of Arcadia Biosciences Inc?

According to Arcadia Biosciences Inc's FY2025 earnings report, its operating profit was -9.99M, with a year-on-year change of -34.02.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy